新十针联合柴胡舒肝散加减治疗慢性胃炎疗效观察.docxVIP

新十针结合柴胡舒肝散加减治疗慢性胃炎疗效观察 〔〕:摘要：目的观察新十针结合柴胡疏肝散加减治疗慢性胃炎证属肝胃不和的临床疗效。方法采取随机数字法,将40例肝胃不和证慢性胃炎病患随机分为对照组20例和治疗组20例。对照组单纯服用柴胡疏肝散加味；治疗组在对照组根底上采用新十针针刺治疗；4周为一个治疗周期。在治疗前后分别对患者进展中医证候积分〔SDSVD〕评定。结果治疗前两组中医证候积分比拟无显著差异；治疗后，治疗组中医证候积清楚显低于对照组〔PNewTenNeedlingbinedwithChaihuShuganSanJiaweiClinicalObservationontheTreatmentofChronicGastritiswithIncoordinationbetweentheLiverandStomachZHAGNHe-xiang1,ZHUQing-jun2*(1.AnhuiUniversityoftraditionalChineseMedicine,HefeiAnhui;2.FirstclinicalmedicalcollegeofAnhuiUniversityoftraditionalChineseMedicine,HefeiAnhui)ABSTRACT:ObjectiveToobservetheclinicaleffectofnewtenneedlingbinedwithchaihushugansanjiaweiintreatmentofpatientswithchronicgastritissyndromeofincoordinationbetweenliverandstomach.Methods40casesofChronicGastritiswithchronicgastritissyndromeofincoordinationbetweenliverandstomachwererandomLydividedintocontrolgroupandtreatmentgroupbyrandomnumbermethod,with20casesineachgroup.Thecontrolgroupwastreatedwithchaihushugansan,atthesametime,thetreatmentgroupwastreatedwiththenewtenneedlingonthebasisofthecontrolgroup,andthecourseforbothgroupswas4w.theTCMsyndromescorewasassessedbeforethetreatmentandafter4weeksofthetreatment.ResultsBeforetreatment,therewasnoobviousdifferenceintheTCMsyndromescorebetweenthetwogroupsbeforetreatment,butaftertreatment,theTCMsyndromescoreinthetreatmentgroupwasobviouslylowerthanthatinthecontrolgroup.ConclusionThecurativeeffectofnewtenneedlingbinedwithchaihushugansanjiaweiintreatmentofpatientswithchronicgastritissyndromeofincoordinationbetweenliverandstomachisobvious.KEYWORDS:Newtenneedle;ChaihuShuganSan;Chronicgastritis;Syndromeofincoordinationbetweenliverandstomach0引言慢性胃炎是临床常见疾病，隶属祖国医学胃脘痛;反酸;痞满;范畴，病情迁延不愈，需要长期服药治疗。在诸多证型中，临床上肝胃不和型慢性胃炎较为常见，故笔者临床观察导师运用新十针;结合柴胡疏肝散加减优化组合的针药合用治慢性胃炎肝胃不和证患者的疗效，现将结果报道如下。1临床资料1.1一般资料所有病例均来自2022年10月至2022年1月安徽中医药大学第一附属医院门诊及住院治疗确实诊慢性胃炎肝胃不和证患者，将40例病患按随机数字法随机分成治疗组及对照组。治疗组20例，女8例，男12例；年龄34~61(46.707.46)岁；病程(15.004.68)月(9个月~24月)；对照组20例，女9例，男11例；年龄31~65(46.439.13)岁；病程(15.104.84)月年(7个月~21